Stimulation of vascularization of a subcutaneous scaffold applicable for pancreatic islet‐transplantation enhances immediate post‐transplant islet graft function but not long‐term normoglycemia
Open Access
- 15 June 2017
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 105 (9) , 2533-2542
Abstract
The liver as transplantation site for pancreatic islets is associated with significant loss of islets, which can be prevented by grafting in a prevascularized, subcutaneous scaffold. Supporting vascularization of a scaffold to limit the period of ischemia is challenging and was developed here by applying liposomes for controlled release of angiogenic factors. The angiogenic capacity of platelet‐derived growth factor, vascular endothelial growth factor, acidic fibroblast growth factor (aFGF), and basic FGF were compared in a tube formation assay. Furthermore, the release kinetics of different liposome compositions were tested. aFGF and L‐α‐phosphatidylcholine/cholesterol liposomes were selected to support vascularization. Two dosages of aFGF‐liposomes (0.5 and 1.0 μg aFGF per injection) were administered weekly for a month after which islets were transplanted. We observed enhanced efficacy in the immediate post‐transplant period compared to the untreated scaffolds. However, on the long‐term, glucose levels of the aFGF treated animals started to increase to diabetic levels. These results suggest that injections with aFGF liposomes do improve vascularization and the immediate restoration of blood glucose levels but does not facilitate the long‐term survival of islets. Our data emphasize the need for long‐term studies to evaluate potential beneficial and adverse effects of vascularization protocols of scaffolds. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 2533–2542, 2017.Keywords
Funding Information
- Diabetes Cell Therapy Initiative (DCTI) (FES 2009 program, Dutch ministry of welfare and sports, and the Dutch diabetes research foundation)
- JDRF short-term fellowship for discovery consortia grant (March 2015)
- JDRF research grant (May 2016)
This publication has 53 references indexed in Scilit:
- Engineered VEGF-releasing PEG–MAL hydrogel for pancreatic islet vascularizationDrug Delivery and Translational Research, 2013
- Reversal of Diabetes by the Creation of Neo-Islet Tissues Into a Subcutaneous Site Using Islet Cell SheetsTransplantation, 2011
- New Alginate Microcapsule System for Angiogenic Protein Delivery and Immunoisolation of Islets for Transplantation in the Rat Omentum PouchTransplantation Proceedings, 2011
- Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in miceDisease Models & Mechanisms, 2010
- Vascular endothelial growth factors and vascular permeabilityCardiovascular Research, 2010
- Current Advances and Travails in Islet TransplantationDiabetes, 2009
- Targeting VEGF‐encapsulated immunoliposomes to MI heart improves vascularity and cardiac functionThe FASEB Journal, 2009
- Revascularization of Transplanted IsletsDiabetes, 2008
- Growth Factor Delivery From Self-Assembling Nanofibers to Facilitate Islet TransplantationTransplantation, 2008
- Long-Term Follow-Up of Oral Glucose Tolerance Test–Derived Glucose Tolerance and Insulin Secretion and Insulin Sensitivity Indexes in Subjects With Glucokinase Mutations (MODY2)Diabetes Care, 2008